company background image
PFE

Pfizer NYSE:PFE Stock Report

Last Price

US$33.62

Market Cap

US$189.8b

7D

-1.3%

1Y

-23.5%

Updated

20 Sep, 2023

Data

Company Financials +

PFE Stock Overview

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

PFE fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends5/6

Pfizer Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pfizer
Historical stock prices
Current Share PriceUS$33.62
52 Week HighUS$54.93
52 Week LowUS$33.44
Beta0.55
1 Month Change-9.16%
3 Month Change-13.19%
1 Year Change-23.45%
3 Year Change-6.61%
5 Year Change-23.03%
Change since IPO1,036.45%

Recent News & Updates

Pfizer: The Floor To This Decline Remains To Be Seen

Sep 02

Pfizer: Searching For A Bottom

Aug 24

Recent updates

Pfizer: The Floor To This Decline Remains To Be Seen

Sep 02

Pfizer: Searching For A Bottom

Aug 24

Pfizer Stock: The Right Time To Buy Now (Technical Analysis)

Aug 17

Pfizer's Unexpected Strength: Bullish Case Emerges Amid New Covid-19 Wave

Aug 11

Pfizer: Significant Plunge, Offering Exceptional Buying Opportunity

Jul 24

Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.41

Jul 17
Pfizer (NYSE:PFE) Has Affirmed Its Dividend Of $0.41

Pfizer: A 4.5% Dividend Yield Is A Gift

Jul 17

Pfizer: A Worthwhile Dividend Play At A Cheap Valuation

Jul 10

Pfizer: Come For The Dividend - Stay For The Dividend

Jun 28

Pfizer's (NYSE:PFE) Dividend Will Be $0.41

Jun 26
Pfizer's (NYSE:PFE) Dividend Will Be $0.41

Shareholder Returns

PFEUS PharmaceuticalsUS Market
7D-1.3%-2.1%-1.5%
1Y-23.5%15.1%13.8%

Return vs Industry: PFE underperformed the US Pharmaceuticals industry which returned 15.1% over the past year.

Return vs Market: PFE underperformed the US Market which returned 13.8% over the past year.

Price Volatility

Is PFE's price volatile compared to industry and market?
PFE volatility
PFE Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement5.6%
10% most volatile stocks in US Market14.3%
10% least volatile stocks in US Market2.5%

Stable Share Price: PFE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: PFE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
184983,000Albert Bourlahttps://www.pfizer.com

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands.

Pfizer Inc. Fundamentals Summary

How do Pfizer's earnings and revenue compare to its market cap?
PFE fundamental statistics
Market CapUS$189.82b
Earnings (TTM)US$21.49b
Revenue (TTM)US$77.94b

8.8x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PFE income statement (TTM)
RevenueUS$77.94b
Cost of RevenueUS$23.52b
Gross ProfitUS$54.42b
Other ExpensesUS$32.93b
EarningsUS$21.49b

Last Reported Earnings

Jul 02, 2023

Next Earnings Date

Oct 31, 2023

Earnings per share (EPS)3.81
Gross Margin69.82%
Net Profit Margin27.58%
Debt/Equity Ratio66.1%

How did PFE perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

42%

Payout Ratio